Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Johnson

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
CA: a Cancer Journal for Clinicians|January 9, 2025
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicineJovanka Gencel-Augusto, Natasha J Minaya, Daniel E Johnson, et al.
Molecular Cancer Therapeutics|November 16, 2004
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptidesSanjeev Shangary, Christopher L Oliver, Tommy S Tillman, et al.
Biochemical and Biophysical Research Communications|June 12, 2026
Constitutively active MEK1 expression driven by the myeloid-selective MRP8 promoter induces epithelial hyperplasia and papilloma formationYan Zang, Ranhui Duan, Michelle B Miranda, et al.
Molecular Oncology|May 13, 2014
Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growthChangyou Li, Ann Marie Egloff, Malabika Sen, et al.
Oral Oncology|November 13, 2013
Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cellsVictor Y Yazbeck, Changyou Li, Jennifer R Grandis, et al.
Molecular Pharmacology|February 28, 2009
ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathwayRongxiu Li, Yan Zang, Changyou Li, et al.
Molecular Cancer Therapeutics|January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistanceChristopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
International Journal of Molecular Sciences|June 1, 2018
Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription FactorDavid S Lee, Rachel A O'Keefe, Patrick K Ha, et al.
Plos One|November 18, 2020
STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumorsThiruganesh Ramasamy, Xucai Chen, Bin Qin, et al.
Molecular Cancer Therapeutics|June 13, 2018
STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung CancerChristian Njatcha, Mariya Farooqui, Adam Kornberg, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
CA: a Cancer Journal for Clinicians|January 9, 2025
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicineJovanka Gencel-Augusto, Natasha J Minaya, Daniel E Johnson, et al.
Molecular Cancer Therapeutics|November 16, 2004
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptidesSanjeev Shangary, Christopher L Oliver, Tommy S Tillman, et al.
Biochemical and Biophysical Research Communications|June 12, 2026
Constitutively active MEK1 expression driven by the myeloid-selective MRP8 promoter induces epithelial hyperplasia and papilloma formationYan Zang, Ranhui Duan, Michelle B Miranda, et al.
Molecular Oncology|May 13, 2014
Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growthChangyou Li, Ann Marie Egloff, Malabika Sen, et al.
Oral Oncology|November 13, 2013
Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cellsVictor Y Yazbeck, Changyou Li, Jennifer R Grandis, et al.
Molecular Pharmacology|February 28, 2009
ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathwayRongxiu Li, Yan Zang, Changyou Li, et al.
Molecular Cancer Therapeutics|January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistanceChristopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
International Journal of Molecular Sciences|June 1, 2018
Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription FactorDavid S Lee, Rachel A O'Keefe, Patrick K Ha, et al.
Plos One|November 18, 2020
STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumorsThiruganesh Ramasamy, Xucai Chen, Bin Qin, et al.
Molecular Cancer Therapeutics|June 13, 2018
STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung CancerChristian Njatcha, Mariya Farooqui, Adam Kornberg, et al.
Pageof 11